Familial combined hyperlipidemia is a polygenic trait.
Gill PK, Hegele RA.
Curr Opin Lipidol. 2022 Apr 1;33(2):126-132. doi: 10.1097/MOL.0000000000000796.
Hyperlipidemia.
Stewart J, McCallin T, Martinez J, Chacko S, Yusuf S.
Pediatr Rev. 2020 Aug;41(8):393-402. doi: 10.1542/pir.2019-0053.
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM.
Biochem Genet. 2022 Apr;60(2):453-481. doi: 10.1007/s10528-021-10130-2. Epub 2021 Sep 3.
New Therapies for Primary Hyperlipidemia.
Aguilar-Salinas CA, Gómez-Díaz RA, Corral P.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1216-1224. doi: 10.1210/clinem/dgab876.
The clinical utility of polygenic risk scores for combined hyperlipidemia.
Dron JS.
Curr Opin Lipidol. 2023 Apr 1;34(2):44-51. doi: 10.1097/MOL.0000000000000865. Epub 2022 Dec 27.
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2023 Sep 11;24(18):13942. doi: 10.3390/ijms241813942.
Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia.
Gill PK, Dron JS, Berberich AJ, Wang J, McIntyre AD, Cao H, Hegele RA.
J Clin Lipidol. 2021 Jan-Feb;15(1):79-87. doi: 10.1016/j.jacl.2020.11.006. Epub 2020 Nov 24.
Exploring the Molecular Mechanism of Action of Yinchen Wuling Powder for the Treatment of Hyperlipidemia, Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.
Ye J, Li L, Hu Z.
Biomed Res Int. 2021 Oct 28;2021:9965906. doi: 10.1155/2021/9965906. eCollection 2021.
Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis.
Tummala R, Gupta M, Devanabanda AR, Bandyopadhyay D, Aronow WS, Ray KK, Mamas M, Ghosh RK.
Ann Med. 2022 Dec;54(1):1287-1296. doi: 10.1080/07853890.2022.2059559.
Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R.
J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16.
